Precise Technologies

Precise Bio is a regenerative medicine company that leverages a proprietary 4D-Bio-Printing platform to develop complex, functional human tissues and organs. The company's technology combines cell biology, biomaterials, and high-resolution printing to create transplantable grafts that address critical unmet needs in ophthalmology and other therapeutic areas. Their lead program is a bio-printed cornea designed to treat corneal blindness, offering a potential alternative to traditional donor transplants. By automating the production of tissues, Precise Bio aims to provide scalable, high-quality regenerative solutions for patients worldwide.